The opioid crisis continues to drive overdose deaths nationwide, and one of the largest correctional systems in the country is responding with a major harm-reduction push. The California Department of Corrections and Rehabilitation (CDCR) has rolled out one of the nation’s most extensive naloxone distribution programs to reverse overdoses among incarcerated people and those reentering …
California Prisons Increase Naloxone Access for Inmates

The opioid crisis continues to drive overdose deaths nationwide, and one of the largest correctional systems in the country is responding with a major harm-reduction push. The California Department of Corrections and Rehabilitation (CDCR) has rolled out one of the nation’s most extensive naloxone distribution programs to reverse overdoses among incarcerated people and those reentering their communities.
As the most populous state in the USA, California features an extensive network of substance abuse programs, starting with local Narcotics Anonymous chapters. But for those incarcerated, extra support is often required. That’s where naloxone distribution comes in.
Naloxone, often known by the brand name Narcan, is a medication that rapidly reverses an opioid overdose by blocking the effects of opioids on the brain. CDCR’s goal is to dramatically expand access at an unprecedented scale to naloxone to decrease overdose deaths in the state’s prisons.
Opioids in the Golden State
The scale of the program reflects just how central naloxone has become to addressing narcotic addiction behind bars and after release. Between 2019 and 2024, CDCR documented more than 7,000 overdose reversals inside prisons, with thousands more expected to add to the tally once 2025 figures are finalized.
The numbers around release planning are even more striking. Since 2020, CDCR has distributed more than 114,000 naloxone kits at the point of release, and over 95% of people leaving custody now receive overdose education along with a kit. In 2025 alone, statewide installation of self-service naloxone dispensers was completed, even through public transportation, and 286,061 kits were distributed.
Staff response to overdoses has also surged. Naloxone administrations by health care staff have increased by roughly 2,000%, while administrations by custody staff jumped by 4,147% since the program began.
Driving the Change
Much of this expansion is happening against the backdrop of a national overdose landscape increasingly shaped by synthetic opioids like fentanyl. Officials often find these drugs mixed together, which has transformed the overdose landscape, both inside correctional facilities and in communities nationwide. Even small amounts of fentanyl can cause a fatal overdose, which is part of why CDCR’s harm reduction strategy treats naloxone access as a baseline safety measure rather than an exception.
CDCR officials describe the expansion effort as part of a systemwide harm-reduction framework. They plan to pair rapid overdose response and broad naloxone access with the program’s medication-assisted treatment (MAT) services.
Deputy Director of Nursing Services Barbara Barney-Knox emphasized the life-saving role naloxone plays in connecting people to longer-term care. She noted nursing staff understand that naloxone access saves lives and preserves the opportunity for life-changing treatment. CDCR leads the way among state correctional systems by making the medication readily available to both staff and incarcerated individuals when it matters most.
Perhaps the most notable policy detail is that while other state prisons also use naloxone, CDCR remains the only state prison system in the country that allows incarcerated individuals to carry naloxone with them, enabling faster peer response when an overdose occurs.
Harm Reduction & Treatment for Opioid Addiction
Naloxone doesn’t treat opioid use disorder itself but can be the difference between life and death during an overdose, buying time for emergency care.
CDCR’s approach reflects a broader trend in addiction medicine: pairing naloxone availability with MAT and peer support. National data show that MAT reduces all-cause mortality among people with opioid use disorder by up to 85% and lowers overdose death risk by 75% after release from incarceration.
CDCR officials note that overdose risk remains especially high for people leaving custody, which is why combining naloxone with treatment infrastructure matters so much for reentry safety. Peer recovery, including Narcotics Anonymous meetings, plays a critical role for people navigating any type of drug dependence during and after reentry.
Help for Opioid Addiction
If you or someone you love has a narcotic addiction or opioid abuse, you can get help either inside and outside the criminal justice system.
- MAT includes methadone, buprenorphine, and naltrexone. When combined with counseling, MAT lowers cravings and relapse rates.
- Naloxone (Narcan) is available without a prescription at most pharmacies in many states, and many community health departments distribute it for free along with fentanyl test strips.
- Narcotics Anonymous meetings offer free and peer-led groups for folks recovering from opioid dependence.
Signing up for NA is super simple. Call 800-934-1582(Sponsored) to speak with an expert for details or look through our directory for chapters anywhere in the country.
the Take-Away